Insulet lifts sales growth forecast on resilient demand for insulin pumpsBusiness, TherapeuticsThe maker of insulin pumps has been trying to ease investor concerns that strong demand for a new class of diabetes drugs that also aid in weight loss could hit the sales of Insulet’s insulin pumps. Read more November 2, 2023/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2015/07/321311_Insuletlogo.jpg 68 300 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2023-11-02 16:30:552023-11-03 09:12:14Insulet lifts sales growth forecast on resilient demand for insulin pumps
FDA Alert: Insulet recalls Omnipod DASH Insulin Management System’s Personal Diabetes Manager for risk of battery swelling, leakage, or extreme overheatingFDA/Regulatory, TherapeuticsThe Class I recall affects nearly 250,000 devices. Read more November 18, 2022/by Administrator https://www.pharmalive.com/wp-content/uploads/2022/05/ReutersFDAlogo5-23-2022.webp 740 1200 Administrator https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Administrator2022-11-18 09:16:492022-11-18 09:16:49FDA Alert: Insulet recalls Omnipod DASH Insulin Management System’s Personal Diabetes Manager for risk of battery swelling, leakage, or extreme overheating
